These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 26525615)
1. [Efficacy of cytoflavin in the treatment of hypoxic-ischemic lesions of the nervous system in 1-month old children with transient neonatal hypothyroidism]. Strukov VI; Maksimova MN; Kuptsova TA; Lysev SF; Shcherbakova YG Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):17-20. PubMed ID: 26525615 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]. Suslina ZA; Klocheva EG; Piradov MA; Rumiantseva SA; Romantsov MG; Kovalenko AL Klin Med (Mosk); 2010; 88(3):50-3. PubMed ID: 20608066 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy of antioxidant energocorreсtion in brain infarction (results of a multicenter randomized trial)]. Rumyantseva SA; Silina EV; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Kovalenko AL; Kabaeva EN; Stupin VA Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):49-55. PubMed ID: 25591516 [TBL] [Abstract][Full Text] [Related]
4. [The efficacy of cytoflavin in the treatment of burnout syndrome]. Chutko LS; Surushkina SY; Yakovenko EA; Rozhkova AV; Anisimova TI; Bondarchuk YL Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):66-70. PubMed ID: 26525625 [TBL] [Abstract][Full Text] [Related]
5. [Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial]. Rumyantsevа SA; Kovalenko AL; Silinа EV; Stupin VA; Kabaeva EN; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Burenichev DV; Golikov KV; Salnikov MV; Belova LA; Mashin VV; Mazina NK; Zhilina EA; Kolotik-Kameneva OY; Sherman MA Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):45-52. PubMed ID: 26356615 [TBL] [Abstract][Full Text] [Related]
6. [Antioxidant therapy in discirculatory encephalopathy]. Antipenko EA; Gustov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819 [No Abstract] [Full Text] [Related]
7. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin]. Madzhidova EN; Usmanova DD; Baĭtursunova ZhM Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414 [TBL] [Abstract][Full Text] [Related]
8. [The use of cytoflavin in reperfusion in ischemic stroke]. Sazonov IE; Lavrenteva IV; Golovina NP Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(3):25-28. PubMed ID: 27070468 [TBL] [Abstract][Full Text] [Related]
9. [The complex energy correction of chronic brain ischemia]. Suslina ZA; Rumiantseva SA; Tanashian MM; Skoromets AA; Klocheva EG; Fedin AI; Kovalenko AL; Silina EV; Sholomov II Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(3):25-30. PubMed ID: 21423112 [TBL] [Abstract][Full Text] [Related]
10. [Clinical-encephalographic evaluation of preterm children treated with cytoflavin during the first year of life]. Rogatkina SO; Degtiareva MG; Grebennikova OV; Volodin NN; Sigova IuA; Asmolova GA; Serova ND Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5):16-23. PubMed ID: 21666588 [TBL] [Abstract][Full Text] [Related]
11. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome]. Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593 [TBL] [Abstract][Full Text] [Related]
12. [Clinical efficacy of cytoflavin in the combined treatment of patients during acute phase of ischemic stroke]. Shestakov VV; Kosenkova NV; Kichigina EV; Larikova TN; Starikova NL Klin Med (Mosk); 2011; 89(1):38-40. PubMed ID: 21516764 [TBL] [Abstract][Full Text] [Related]
13. [Cytoflavin in the complex treatment of neuroinfections in children]. Skripchenko NV; Egorova ES Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9):28-31. PubMed ID: 22027666 [TBL] [Abstract][Full Text] [Related]
14. [The improvement of treatment efficacy in newborn full-term infants with severe birth asphyxia]. Skoromets AP; Schugareva LM; Shumilina MV; Gorelik YV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(4 Pt 2):83-88. PubMed ID: 27456726 [TBL] [Abstract][Full Text] [Related]
15. [Performance evaluation of integrated cytoprotective therapy of different duration in patients with cerebral infarction]. Chichanovskaia LV; Tsukurova LA; Kovalenko AL; Nazarov MV; Lukin DI; Rumiantseva SA; Silina EV; Stupin VA; Nedorostkova TIu; Kabaeva EN; Eliseev EV Eksp Klin Farmakol; 2015; 78(1):21-6. PubMed ID: 25826870 [TBL] [Abstract][Full Text] [Related]
16. [An effect of cytoprotective therapy on stress resistance and compensatory abilities of patients with chronic cerebral ischemia]. Antipenko EA; Derugina AV; Gustov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):74-78. PubMed ID: 26978497 [TBL] [Abstract][Full Text] [Related]
17. [EFFICACY OF CYTOFLAVIN IN COMPLEX TREATMENT OF DIABETIC FOOT SYNDROME]. Skrypko V; Kovalenko A; Zaplutanov V; Kharitonova T; Myhaloyko I Georgian Med News; 2017 Apr; (265):14-19. PubMed ID: 28574379 [TBL] [Abstract][Full Text] [Related]
18. [The use of citoflavin in neonatology and pediatrics as a factor improving therapeutic efficacy in patients with central nervous system lesions of various etiology]. Koval'chuk VV; Zuyeva IB; Nesterin KV; Verulashvili IV; Kortushvili MG Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5. Vyp. 2):46-50. PubMed ID: 30141787 [TBL] [Abstract][Full Text] [Related]
19. [The use of cytoflavin for the treatment of chronic brucellosis]. Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of cytoflavin in the treatment of burns patients with toxic and post-hypoxic encephalopathy]. Pochepen' ON Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):23-9. PubMed ID: 21183910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]